Case number 1:22-cv-00162
Acerta Pharma B.V. et al v. Cipla Limited et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 27, 2022 | 33 | Notice of Service (6) Docket Text: NOTICE OF SERVICE of Plaintiffs' Initial Disclosures Pursuant to paragraph 4(a) of the Delaware Default Standard for Discovery filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V..(Silver, Daniel) |
| Jun 22, 2022 | 32 | Certification for Jihad Komis (1) |
| Jun 22, 2022 | 32 | Main Document (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jihad Komis - filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Attachments: # (1) Certification for Jihad Komis)(Joyce, Alexandra) |
| Jun 22, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (27 in 22-cv-155-RGA; 28 in 22-cv-163-RGA; 36 in 22-cv-154-RGA; 32 in 22-cv-164-RGA; 32 in 22-cv-162-RGA) MOTION for Pro Hac Vice Appearance of Attorney Jihad Komis, filed by Merck Sharp & Dohme B.V., AstraZeneca UK Limited, AstraZeneca Pharmaceuticals LP, AstraZeneca AB, Acerta Pharma B.V.. Signed by Judge Richard G. Andrews on 6/22/2022. Associated Cases: 1:22-cv-00154-RGA, 1:22-cv-00155-RGA, 1:22-cv-00162-RGA, 1:22-cv-00163-RGA, 1:22-cv-00164-RGA(nms) |
| May 13, 2022 | 31 | Scheduling Order (13) Docket Text: SCHEDULING ORDER: Joinder of Parties due by 1/9/2023. Amended Pleadings due by 1/9/2023. Fact Discovery completed by 2/12/2024. Joint Claim Construction Brief due by 7/31/2023. A Markman Hearing is set for 8/31/2023, at 9:00 AM in Courtroom 6A. A Pretrial Conference is set for 2/21/2025, at 9:00 AM in Courtroom 6A. A 3 day Bench Trial on invalidity is set to start 3/3/2025, at 8:30 AM in Courtroom 6A. One day Bench Trials on infringement is set to start 3/10/2025, at 8:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 5/13/2022. Associated Cases: 1:22-cv-00154-RGA, 1:22-cv-00155-RGA, 1:22-cv-00162-RGA, 1:22-cv-00163-RGA, 1:22-cv-00164-RGA(nms) |
| May 13, 2022 | 30 | Proposed Order (15) Docket Text: PROPOSED Scheduling Order, by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Joyce, Alexandra) Modified on 5/13/2022 (nms). |
| May 11, 2022 | N/A | Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Richard G. Andrews - Rule 16(b) Telephone Scheduling Conference held on 5/11/2022. Counsel for Plaintiffs: A. Joyce. Counsel for Defendants: D. Gattuso, M. Haney, M. Goeller. A 3-day Bench Trial on Invalidity is scheduled to begin on 3/3/2025. A Pretrial Conference is set for 2/21/2025, at 9:00 AM. Plaintiff's are directed to resubmit the proposed scheduling order reflecting the rulings the Court made during the hearing. (Court Reporter Heather Triozzi.) Associated Cases: 1:22-cv-00154-RGA, 1:22-cv-00155-RGA, 1:22-cv-00162-RGA, 1:22-cv-00163-RGA, 1:22-cv-00164-RGA(lak) |
| May 10, 2022 | 29 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Alexander S. Zolan - filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Joyce, Alexandra) |
| May 10, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Alexander S. Zolan for Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, and Merck Sharp & Dohme B.V. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| May 10, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (D.I. 24 in 22-cv-155-RGA; D.I. 28 in 22-cv-154-RGA; D.I. 29 in 22-cv-164-RGA; D.I. 29 in 22-cv-162-RGA; D.I. 24 in 22-cv-163-RGA) MOTION for Pro Hac Vice Appearance of Attorney Alexander S. Zolan, filed by Merck Sharp & Dohme B.V., AstraZeneca UK Limited, AstraZeneca Pharmaceuticals LP, AstraZeneca AB, Acerta Pharma B.V.. Signed by Judge Richard G. Andrews on 5/10/2022. Associated Cases: 1:22-cv-00154-RGA, 1:22-cv-00155-RGA, 1:22-cv-00162-RGA, 1:22-cv-00163-RGA, 1:22-cv-00164-RGA(nms) |
| May 9, 2022 | 28 | Letter (1) Docket Text: Letter to The Honorable Richard G. Andrews from Alexandra M. Joyce, Esq. regarding Dial-In for Rule 16 Teleconference. (Joyce, Alexandra) |
| May 9, 2022 | 27 | Proposed Order (16) Docket Text: PROPOSED Scheduling Order, by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Joyce, Alexandra) Modified on 5/10/2022 (nms). |
| Apr 29, 2022 | 26 | Notice of Change of Address (2) Docket Text: NOTICE of Change of Address by Alexandra M. Joyce (Joyce, Alexandra) |
| Apr 28, 2022 | 25 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME the Deadline for Plaintiffs to Answer, Move, or Respond to the Counterclaims to May 16, 2022 - filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Joyce, Alexandra) |
| Apr 28, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (D.I. 25 in 22-cv-162-RGA; D.I. 25 in 22-cv-164-RGA; D.I. 24 in 22-cv-154-RGA; D.I. 19 in 22-cv-163-RGA) STIPULATION and Proposed Order to Extend Time to Answer, Move, or Respond to the Counterclaims to May 16, 2022. Signed by Judge Richard G. Andrews on 4/28/2022. Associated Cases: 1:22-cv-00154-RGA, 1:22-cv-00162-RGA, 1:22-cv-00163-RGA, 1:22-cv-00164-RGA(nms) |
| Apr 18, 2022 | 24 | Redacted Document (30) Docket Text: REDACTED VERSION of [16] Answer to Complaint,, Counterclaim, by Cipla Limited, Cipla USA, Inc.. (Caponi, Steven) |
| Apr 13, 2022 | 23 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Cipla Limited, Cipla USA, Inc.. (Caponi, Steven) |
| Apr 13, 2022 | 22 | Order Setting Scheduling Conference (1) Docket Text: Order Setting Rule 16(b) Telephone Conference: A Scheduling Conference is set for 5/11/2022, at 3:00 PM before Judge Richard G. Andrews (see Order for further details). Signed by Judge Richard G. Andrews on 4/13/2022. (nms) |
| Apr 13, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys Anil H. Patel, Jenna Bruce, Peter L. Giunta, and Harold M. Storey for Cipla Limited and Cipla USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (srs) |
| Apr 12, 2022 | 21 | Order (2) Docket Text: SO ORDERED Granting [15] Stipulation and [Proposed] Order Regarding Motion to Seal Defendants' Answer and Counterclaims. Signed by Judge Richard G. Andrews on 4/12/2022. (nms) |
| Apr 12, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The unopposed motion to seal the answer and counterclaims (D.I. [14]) is GRANTED. Ordered by Judge Richard G. Andrews on 4/12/2022. (nms) |
| Apr 12, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The six exhibits found at D.I. [16] are STRUCK. They are absolutely superfluous to the counterclaims stating claims, and completely unnecessary at the pleading stage. Ordered by Judge Richard G. Andrews on 4/12/2022. (nms) |
| Apr 12, 2022 | 18 | Letter (1) Docket Text: Letter to the Honorable Richard G. Andrews, from Steven L. Caponi, regarding Exhibits 1-6 to Defendants' counterclaims. (Caponi, Steven) Modified on 4/12/2022 (nms). |
| Apr 12, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER: Defendants are requested to respond to why I should not simply strike Exhibits 1-6 as being unnecessary to the Answer. Ordered by Judge Richard G. Andrews on 4/12/2022. (nms) |
| Apr 11, 2022 | 14 | Text of Proposed Order (3) |
| Apr 11, 2022 | 14 | Rule 7.1.1 Certificate (1) |
| Apr 11, 2022 | 14 | Main Document (5) Docket Text: Unopposed Motion to File Under Seal - filed by Cipla Limited, Cipla USA, Inc.. (Attachments: # (1) Proposed Order, # (2) 7.1.1 Certificate)(Goeller, Matthew) Modified on 4/11/2022 (nms). |
| Apr 11, 2022 | 15 | Stipulation (2) Docket Text: STIPULATION and [Proposed] Order Regarding Motion to Seal Defendants' Answer, Counterclaims, and Exhibits, by Cipla Limited, Cipla USA, Inc.. (Goeller, Matthew) Modified on 4/11/2022 (nms). |
| Apr 7, 2022 | 13 | Motion for Leave to Appear Pro Hac Vice (6) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Anil H. Patel, Harold Storey, Jenna Bruce and Peter Giunta - filed by Cipla Limited, Cipla USA, Inc.. (Caponi, Steven) |
| Apr 7, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [13] MOTION for Pro Hac Vice Appearance of Attorney Anil H. Patel, Harold Storey, Jenna Bruce and Peter Giunta, filed by Cipla Limited, Cipla USA, Inc.. Signed by Judge Richard G. Andrews on 4/7/2022. (nms) |
| Mar 2, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Kevin Hoagland-Hanson, Min Kyung Jeon, Stanley E. Fisher, David I. Berl, and Sarahi Uribe for Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V., added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:22-cv-00154-RGA, 1:22-cv-00155-RGA, 1:22-cv-00162-RGA, 1:22-cv-00163-RGA, 1:22-cv-00164-RGA(smg) |
| Feb 23, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [12] STIPULATION and Proposed Order Extending Time for Response to Complaint (*Reset Answer Deadlines: Cipla Limited answer due 4/11/2022; Cipla USA, Inc. answer due 4/11/2022). Signed by Judge Richard G. Andrews on 2/23/2022. (nms) |
| Feb 22, 2022 | 12 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION and Proposed Order Extending Time for Response to Complaint - filed by Cipla Limited, Cipla USA, Inc.. (Caponi, Steven) Modified on 2/23/2022 (nms). |
| Feb 17, 2022 | 11 | Certifications for David I. Berl, Stanley E. Fisher, Kevin Hoagland-Hanson, Sar (5) |
| Feb 17, 2022 | 11 | Main Document (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney David I. Berl, Stanley E. Fisher, Kevin Hoagland-Hanson, Sarahi Uribe, and Min Kyung Jeon - filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Attachments: # (1) Certifications for David I. Berl, Stanley E. Fisher, Kevin Hoagland-Hanson, Sarahi Uribe, and Min Kyung Jeon)(Joyce, Alexandra) |
| Feb 17, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (12 in 22-cv-164-RGA; 11 in 22-cv-155-RGA; 11 in 22-cv-162-RGA; 11 in 22-cv-163-RGA; 11 in 22-cv-154-RGA) MOTION for Pro Hac Vice Appearance of Attorney David I. Berl, Stanley E. Fisher, Kevin Hoagland-Hanson, Sarahi Uribe, and Min Kyung Jeon, filed by Merck Sharp & Dohme B.V., AstraZeneca UK Limited, AstraZeneca Pharmaceuticals LP, AstraZeneca AB, Acerta Pharma B.V.. Signed by Judge Richard G. Andrews on 2/17/2022. Associated Cases: 1:22-cv-00154-RGA, 1:22-cv-00155-RGA, 1:22-cv-00162-RGA, 1:22-cv-00163-RGA, 1:22-cv-00164-RGA(nms) |
| Feb 9, 2022 | 10 | Exhibit A-B (7) |
| Feb 9, 2022 | 10 | Main Document (2) Docket Text: DECLARATION of Service of Cipla Limited, by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Attachments: # (1) Exhibits A-B)(Joyce, Alexandra) Modified on 2/9/2022 (nms). |
| Feb 9, 2022 | 9 | Exhibit A-B (7) |
| Feb 9, 2022 | 9 | Main Document (2) Docket Text: DECLARATION of Service of Cipla USA, Inc., by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V.. (Attachments: # (1) Exhibits A-B)(Joyce, Alexandra) Modified on 2/9/2022 (nms). |
| Feb 9, 2022 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:22-cv-00154-RGA, 1:22-cv-00155-RGA, 1:22-cv-00162-RGA, 1:22-cv-00163-RGA, 1:22-cv-00164-RGA (rjb) |
| Feb 4, 2022 | 1 | Main Document (25) Docket Text: COMPLAINT filed against Cipla Limited and Cipla USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3796360.) - filed by AstraZeneca UK Limited, Acerta Pharma B.V., AstraZeneca Pharmaceuticals LP, Merck Sharp & Dohme B.V., and AstraZeneca AB. (Attachments: # (1) Exhibit A-F, # (2) Civil Cover Sheet)(srs) |
| Feb 4, 2022 | 8 | Summons Issued (2) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Cipla Limited on 2/4/2022. (srs) |
| Feb 4, 2022 | 7 | Summons Issued (2) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Cipla USA, Inc. on 2/4/2022. (srs) |
| Feb 4, 2022 | 6 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited. (srs) |
| Feb 4, 2022 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Merck & Co., Inc. for Merck Sharp & Dohme B.V. filed by Merck Sharp & Dohme B.V. (srs) |
| Feb 4, 2022 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,758,524 ;10,239,883 ;9,796,721 ;10,167,291 ;10,272,083. (srs) |
| Feb 4, 2022 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: No earlier than December 29, 2021. Date of Expiration of Patent: 9,758,524 - July 11, 2032, 10,239,883- July 11, 2032, 9,796,721 - July 1, 2036, 10,167,291 - July 1, 2036, 10,272,083 January 21, 2035. Thirty Month Stay Deadline: No Earlier than April 30, 2025. |
| Feb 4, 2022 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (srs) |
| Feb 4, 2022 | 1 | Civil Cover Sheet (2) |
| Feb 4, 2022 | 1 | Exhibit A-F (520) |
| Feb 4, 2022 | 1 | Complaint* (1) |
